Yuan Yuzhang, Zhang Haozhe, Wang Zehua, Huang Luying, Kabacaoglu Derya, Zhang Boxing, Song Liang, Ai Jiaoyu
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Front Immunol. 2025 Aug 28;16:1625114. doi: 10.3389/fimmu.2025.1625114. eCollection 2025.
Pancreatic cancer (PC) is an aggressive malignancy with a poor prognosis, and the tumor microenvironment (TME) plays a pivotal role in its initiation, progression, and response to treatment. Recent studies have highlighted the critical involvement of inflammatory factors in shaping and sustaining the PC microenvironment. Chronic inflammation is a hallmark of this cancer, with inflammatory molecules such as cytokines, chemokines, proteases, and other immune-modulatory factors driving tumor cell proliferation, metastasis, and resistance to therapy. These inflammatory factors exert their effects by modulating immune cell infiltration, extracellular matrix (ECM) remodeling, and angiogenesis. This review provides an overview of the diverse roles of inflammatory factors in the PC TME and explores their potential as therapeutic targets. It offers new perspectives for developing novel immunotherapies and inflammation-modulating strategies to improve the treatment of PC.
胰腺癌(PC)是一种侵袭性恶性肿瘤,预后较差,肿瘤微环境(TME)在其发生、发展及对治疗的反应中起关键作用。最近的研究强调了炎症因子在塑造和维持胰腺癌微环境中的关键作用。慢性炎症是这种癌症的一个标志,细胞因子、趋化因子、蛋白酶和其他免疫调节因子等炎症分子可驱动肿瘤细胞增殖、转移及产生治疗抗性。这些炎症因子通过调节免疫细胞浸润、细胞外基质(ECM)重塑和血管生成发挥作用。本综述概述了炎症因子在胰腺癌TME中的多种作用,并探讨了它们作为治疗靶点的潜力。它为开发新型免疫疗法和炎症调节策略以改善胰腺癌治疗提供了新的视角。